🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jared Weiss

University of North Carolina at Chapel Hill

ORCID: 0000-0003-2961-4447
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Table S2 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.22481301
Top 100%
0DataRank
Top 100%0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Papers

Driven by 10 papers — median percentile 0. Top paper: “Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial”.

Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00541-1
N/A
5.0DataRank · unranked
426 citations

Jürgen Wolf, Bhavana Konda, Hyunseok Kang, Alexander I. Spira, Jared Weiss +10 more

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0800
N/A
3.5DataRank · unranked
140 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration

Nature Medicine(2020)10.1038/s41591-019-0716-8
N/A
0.898DataRank · unranked
397 citations

Jeffrey W. Clark, Jared Weiss, Sai‐Hong Ignatius Ou, D. Ross Camidge, Benjamin Solomon +16 more

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration

Nature Communications(2022)10.1038/s41467-022-29647-0
N/A
0.697DataRank · unranked
103 citations

Emily B. Harrison, Huizhong Li, Koichi Hirabayashi, Jing Chen, Henry Li +8 more

Landscape and selection of vaccine epitopes in SARS-CoV-2

Genome Medicine(2021)10.1186/s13073-021-00910-1
N/A
0.614DataRank · unranked
59 citations

Kelly Olsen, Kaylee M. Gentry, Maria J. Sambade, Wolfgang Beck, Jason Garness +23 more

Feasibility, Acceptability, and Utility of Remote Patient-Reported Outcomes Monitoring in Patients With Lung Cancer: A Moovcare© Study

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.07.016
N/A
0.165DataRank · unranked
2 citations

Allison M. Deal, Chaely J Medley, Ashley A. Weiner, Lara Novak, Amanda Gentry +10 more

Data from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.c.6530655.v1
N/A
0DataRank · unranked
0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Supplementary Table S2 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.22481301
Top 100%
0DataRank
Top 100%0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

UNC Libraries(2024)10.17615/v63y-ya13
N/A
0DataRank · unranked
0 citations

Giovanni Fucà, Jared Weiss, Barbara Savoldo, Loïc Reppel, Pecot C.V +5 more

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003897
N/A
0DataRank · unranked
73 citations

Ourania Tsahouridis, Jason Akulian, Ian J. Davis, Hong Lee, Giovanni Fucà +5 more